Identifying The Optimal Therapeutic Applications for Your Inflammasome Inhibitor – Avoid InfiniteThink!
Time: 9:00 am
day: Day Two
- Therapeutic options for inflammasome inhibitors seem infinite – this presentation will address key considerations for narrowing the list to those with the highest potential for clinical and commercial success
- Disease pathogenesis
- Models for preclinical proof-of-concept
- Unmet medical and patient needs
- Differentiation from current and pipeline competitors